Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Inhalant Solution

Known as: Inhalation Solutions, Inhalant Solution [Dose Form], Inhalant Solution Dosage Form 
Liquid medication intended to be inhaled.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND The clinical benefit of inhaled antibiotics in non-cystic fibrosis bronchiectasis has not been established in… 
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Highly Cited
2013
Highly Cited
2013
BACKGROUND Open-label, parallel-group, international trial comparing aztreonam for inhalation solution (AZLI) and tobramycin… 
Highly Cited
2011
Highly Cited
2011
OBJECTIVE To investigate the efficacy and safety of 4 antipseudomonal treatments in children with cystic fibrosis with recently… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2011
Highly Cited
2011
BACKGROUND A light-porous-particle, dry-powder formulation of tobramycin was developed, using PulmoSphere® technology, to improve… 
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Highly Cited
2011
Highly Cited
2011
Tobramycin inhalation solution is used to treat chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients… 
Highly Cited
2011
Highly Cited
2011
BACKGROUND Previous aztreonam for inhalation solution (AZLI) studies included patients with cystic fibrosis, Pseudomonas… 
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 2
Highly Cited
2011
Highly Cited
2011
RATIONALE Lower respiratory tract infection with Pseudomonas aeruginosa (PA) is associated with increased morbidity in patients… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2010
Highly Cited
2010
Chronic airway infection with Pseudomonas aeruginosa (PA) causes morbidity and mortality in patients with cystic fibrosis (CF… 
Highly Cited
2009
Highly Cited
2009
Rationale Antibiotic therapy for early Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF) is effective, but… 
Highly Cited
1997
Highly Cited
1997
STUDY OBJECTIVE We compared the long-term safety and efficacy of the combination ipratropium bromide (IB) and albuterol sulfate…